| Active substance |
Olmesartan |
| Also known as |
Olmetec |
| Blood pressure |
Reduces systolic and diastolic blood pressure |
| Chemical name |
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate |
| Dosage (medical) |
Typically starting at 20 mg once daily, can be increased to 40 mg once daily |
| Dosage (sports) |
Not applicable |
| Effects |
Lowers blood pressure, reduces the risk of stroke and heart attack |
| Formula |
C29H30N6O6 |
| Half-life |
Approximately 13 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Monitoring of blood pressure and renal function |
| Main action |
Antihypertensive |
| Side effects |
Dizziness, headache, diarrhea, abdominal pain, fatigue, hyperkalemia, rare cases of angioedema |
| Storage conditions |
Store at room temperature, protect from moisture and light |
| Strength |
40mg |
| Substance class |
Angiotensin II receptor blocker |
| Trade name |
Benicar |
| Use in sports |
Not commonly used in sports |
| Manufacturer |
Helios Pharmaceuticals |
| Packing |
10 tabs/blister |
